Background. Recent efforts to provide an annual profile of the health care quality of the
nation's health care delivery system and to identify health care disparities in the population's …

The published results of the post-marketing ORAL Surveillance study, which compared the
Janus kinase (JAK) inhibitor tofacitinib with anti-TNF therapy in older patients with …

PURPOSE: We present a systematic review of the current literature regarding the use of the
2 most common surgical treatments for lesions of the long head of the biceps brachii, …

… Cohen has received consulting fees or honoraria (less than $10,000 per year) from Abbott,
Genentech, Biogen IDEC, Scios, Amgen, Sanofi-Aventis, Chelsea Therapeutics, and Xencor. …

… Cohen has received honoraria (less than $10,000 each) from Genentech, Biogen Idec,
Scios, and Amgen. Dr. Emery has received honoraria (less than $10,000) from Genentech. …

In the Multicenter Trial of Cryotherapy for Retinopathy of Prematurity (ROP), 4099 infants
weighing less than 1251 g at birth underwent sequential ophthalmic examinations, beginning at …

Recent reports of increased tolerance to artemisinin derivatives—the most recently adopted
class of antimalarials—have prompted a need for new treatments. The spirotetrahydro-β-…

Background Receptor activator of nuclear factor-κB ligand (RANKL) is essential for osteoclast
differentiation, activation, and survival. The fully human monoclonal antibody denosumab (…

We introduce extreme summarization, a new single-document summarization task which does
not favor extractive strategies and calls for an abstractive modeling approach. The idea is …

… Cohen… Mease, Siegel, Cohen, and Ory have received consulting fees and honoraria
from Amgen. Drs. Mease, Kivitz, and Siegel have stock ownership or options in Amgen. …